Position in COLL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$12,470,900
+$1,055,136 QoQ
Shares Held
344,500
-0.2% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#26
of 277 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LSV ASSET MANAGEMENT holds $404,370,158 across 20 Drug Manufacturers - Specialty & Generic names. COLL ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
268,370 | $145,410,917 | |
| 2 | VTRS |
Viatris Inc
|
8,555,180 | $135,856,258 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,024,724 | $42,044,425 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
608,376 | $15,434,499 | |
| 5 | EBS |
Emergent BioSolutions Inc.
|
1,695,851 | $14,211,231 | |
| 6 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
642,014 | $12,955,842 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
This page
|
344,500 | $12,470,900 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
76,400 | $8,475,816 |
All Filings in COLL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,470,900 | 344,500 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $11,415,764 | 345,200 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $16,107,770 | 347,900 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $12,127,534 | 346,600 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $10,346,543 | 349,900 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $11,464,041 | 384,055 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $11,186,421 | 390,451 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,436,338 | 451,251 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $12,253,742 | 380,551 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $14,772,989 | 380,551 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $4,056,804 | 131,800 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,682,955 | 75,300 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $5,815,194 | 270,600 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $5,776,792 | 240,800 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $5,514,640 | 237,700 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,838,392 | 239,600 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $6,334,900 | 357,500 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $7,329,600 | 360,000 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,758,424 | 361,800 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $2,899,806 | 146,900 | Shares | Sole | 2021-11-04 | |
| No filing history on record for this holder in this stock. | ||||||